Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Zero Based Budgeting For Low Income Families Examples show accessible approaches to allocate limited resources without sacrificing essentials.
22,691 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Meta Platforms unveils a multi-year AI infrastructure push totaling up to $145 billion, reshaping supplier valuations...
Kennametal’s Q3 2026 results shed light on the company’s path through a challenging manufacturing environment. This a...
A small group of under-the-radar stocks is flashing AI-like growth signals while remaining off the radar of most inve...
The SEC signals a potential rulemaking push for onchain market structures and software apps, aiming to bring clarity ...
Exploring the key differences between spdr gold shares ishares and IAU helps investors pick the right gold ETF for tr...
The AI chip rally is shifting from training to real-world inference. This article explains why the next phase chip su...
Ethereum is the lone red stake among the top-10 cryptos this week, while Bitcoin and other large caps post gains as i...
A Houston geothermal startup storms Wall Street, delivering the clean energy sector’s largest IPO to date with a $10B...
Bitcoin spent the week wavering around the 80K level, briefly spiking above, then slipping as inflation data and regu...
In May 2026, additive manufacturing stocks are catching fresh interest as manufacturers push for faster production cy...
Bitcoin fell to a two-week low as leveraged bets were wiped out and risk appetite faded amid geopolitical tensions an...